221 related articles for article (PubMed ID: 36514118)
21. Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.
Nishikawa R; Yoshida K; Ebina Y; Omoteda M; Miyawaki D; Ishihara T; Ejima Y; Akasaka H; Satoh H; Kyotani K; Takahashi S; Sasaki R
J Radiat Res; 2018 May; 59(3):316-326. PubMed ID: 29518234
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
[TBL] [Abstract][Full Text] [Related]
23. Clinical Outcomes and Dosimetric Evaluationof Interstitial Brachytherapyin Gynecological Malignancies.
V VN; Dharmarajan A; Jones J; Yahiya EKN; Muttath G; Sneha N
Gulf J Oncolog; 2024 May; 1(45):69-74. PubMed ID: 38774935
[TBL] [Abstract][Full Text] [Related]
24. Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.
Harkenrider MM; Surucu M; Harmon G; Mysz ML; Shea SM; Yacoub J; Goldberg A; Liotta M; Winder A; Potkul R; Roeske JC; Small W
Brachytherapy; 2018; 17(1):187-193. PubMed ID: 29089277
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
[TBL] [Abstract][Full Text] [Related]
26. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
[TBL] [Abstract][Full Text] [Related]
27. Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity.
Amsbaugh MJ; Bhatt N; Hunter T; Gaskins J; Parker L; Metzinger D; Amsbaugh A; Sowards K; El-Ghamry MN
Brachytherapy; 2016; 15(1):49-56. PubMed ID: 26614237
[TBL] [Abstract][Full Text] [Related]
28. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance image-based 3D volume interstitial brachytherapy using polyether ether ketone catheters in advanced cervical cancer - a feasibility study.
Palled SR; Tanvirpasha CAR; Naveen T; Sathiyan S; Kadirampatti G; Lokesh V
J Contemp Brachytherapy; 2019 Aug; 11(4):307-311. PubMed ID: 31523230
[TBL] [Abstract][Full Text] [Related]
30. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
Sharma M; Fields EC; Todor DA
Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
[TBL] [Abstract][Full Text] [Related]
31. A dosimetric comparison of Volumetric Modulated Arc Therapy (VMAT) and High Dose Rate (HDR) brachytherapy in localized cervical cancer radiotherapy.
Wali L; Helal A; Darwesh R; Attar M
J Xray Sci Technol; 2019; 27(3):473-483. PubMed ID: 30958322
[TBL] [Abstract][Full Text] [Related]
32. Intracavitary brachytherapy with additional Heyman capsules in the treatment of cervical cancer.
Scharl S; Hugo C; Weidenbächer CB; Bronger H; Brambs C; Kiechle M; Makowski MR; Combs SE; Schüttrumpf L
Arch Gynecol Obstet; 2023 Feb; 307(2):557-564. PubMed ID: 35639163
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer.
Mohamed S; Nielsen SK; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
Radiother Oncol; 2013 Apr; 107(1):32-8. PubMed ID: 23333020
[TBL] [Abstract][Full Text] [Related]
34. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
[TBL] [Abstract][Full Text] [Related]
35. Dosimetric comparison of interstitial brachytherapy with multi-channel vaginal cylinder plans in patients with vaginal tumors.
Mendez LC; Paudel M; Wronski M; Ravi A; Barbera L; Leung E
Radiat Oncol; 2017 May; 12(1):84. PubMed ID: 28521759
[TBL] [Abstract][Full Text] [Related]
36. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
[TBL] [Abstract][Full Text] [Related]
37. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
[TBL] [Abstract][Full Text] [Related]
38. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
Nickers P; Thissen B; Jansen N; Deneufbourg JM
Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
40. Calculation of dose volume parameters and indices in plan evaluation of HDR interstitial brachytherapy by MUPIT in carcinoma cervix.
Poddar J; Sharma AD; Suryanarayan U; Shah SP; Parikh A; Mehta V; Kumar T
Indian J Cancer; 2018; 55(3):238-241. PubMed ID: 30693886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
